The WVU Cancer Institute’s Cancer Prevention and Control has expanded its Bridge Program that focuses on lung cancer survivorship to United Hospital Center (UHC) in Bridgeport. The goal of the Bridge Program is to improve the coordination of care and decrease the consequences of treatment for patients diagnosed with stage I, II, or III lung cancer after they complete treatment.
“It has been an exciting opportunity to be part of this project from the early stages with the WVU Cancer Institute, as a gap in care has been identified for the lung cancer survivors of West Virginia,” Linda Carte, RN, MSN, AOCN, vice president of oncology and post-acute care at United Hospital Center, said. “While lung cancer survivors are the first to have the opportunity to participate in this Bridge Program, it is a model that can certainly be extended to all those surviving cancer to improve quality of life after diagnosis and treatment. We are looking forward to this ongoing collaboration to improve cancer care for the many communities we serve.”
The Bridge Program brings together healthcare professionals from multiple disciplines to create a comprehensive care plan tailored to the specific needs of each patient. During a half-day clinic, each patient has the opportunity to meet individually with a nurse practitioner, licensed social worker, dietitian, psychiatrist, physical therapist, and occupational therapist.
The program is funded by the Bristol-Myers Squibb Foundation’s "Bridging Cancer Care" initiative.
Defense Health Program
The WVU Cancer Institute is applying for a Certificate of Need with the West Virginia Health Care Authority for a mobile lung cancer screening program, which will be called LUCAS. This program would increase access to screening for patients in rural areas and address the growing demand for cancer services in the state.
WVU Medicine Physician Presents at International Society of Intraoperative Radiation Therapy Conference
Christopher P. Cifarelli, M.D., Ph.D., Director of the WVU Medicine Gamma Knife program and member of the WVU Cancer Institute Research Programs, presented a talk on his team’s research during the 2018 ISIORT conference in Mannheim, Germany. Dr. Cifarelli presented two sessions: Feasibility of Dose Escalation Using Intraoperative Radiotherapy Following Resection of Large Brain Metastases Compared to Post-operative SRS and Neurosurgical Nuances of IORT for Intracranial Lesions. The work focuses on a novel use of radiation delivered to the brain at the time of surgery as a means to decrease long-term radiation doses and improve overall outcomes for patients with metastatic and primary brain tumors. The conference had about 300 specialists from over 20 nations in attendance. Dr. Cifarelli is a faculty member in the WVU Department of Neurosurgery and a member of the Radiation Oncology team at WVU Cancer Institute. This work was co-authored by Joshua Hack MS, Geraldine M. Jacobson MD, and J. Austin Vargo MD.